Questions Over ' Flu Jab ' in Lung Cancer Patients on PD Inhibitors Questions Over ' Flu Jab ' in Lung Cancer Patients on PD Inhibitors

Patients with cancer receiving immune checkpoint inhibitors could be at increased risk for adverse events compared with the general population if they are given a yearly flu jab, say Swiss researchers.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news